Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPathfinder Minerals Regulatory News (PFP)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Pathfinder Minerals (PFP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
PFP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Bilateral Investment Treaty Claim

29 Sep 2022 07:00

RNS Number : 0814B
Pathfinder Minerals Plc
29 September 2022
 

29 September 2022

 

Pathfinder Minerals Plc

("Pathfinder" the "Company")

 

Update Re Bilateral Investment Treaty Claim:

Option Agreement for the Sale of IM Minerals and the Claim

 

Pathfinder announces that it has entered into an option agreement with Acumen Advisory Group LLC ("AAG"), an asset recovery specialist incorporated in Delaware, USA, with a track record of international claim enforcement, under which Pathfinder has granted AAG an exclusive option to acquire IM Minerals Limited ("IMM"), a wholly owned subsidiary of Pathfinder, and the rights to bring a claim against the Government of Mozambique (the "Claim") under the Mozambique-United Kingdom Bilateral Investment Treaty (2004) (the "Option Agreement"), for the expropriation of Mining Concession 4623C (the "Licence").

 

Summary:

 

· Exclusive option granted to AAG for a period of three months to 27 December 2022 (unless extended) to enable AAG to complete due diligence and enter into binding definitive documentation in respect of the acquisition of IMM and the rights to the Claim (the "Acquisition Agreement")

If rights under the Option Agreement are exercised and the Acquisition Agreement is entered into, it would, subject to fulfilling certain conditions precedent, result in:

 

· Payment of £2 million in cash to Pathfinder by AAG for the acquisition of 100% of IMM on signature of the Acquisition Agreement

· Binding commitment by AAG to commence legal proceedings against the Government of Mozambique in respect of the Claim within three months of completion of the Acquisition Agreement with AAG confirming that it has secured at least US$15 million and will use its best endeavours to pursue the Claim to a satisfactory conclusion within five years

· Contingent payment by AAG to Pathfinder of US$24 million or 20% of net recoveries (whichever is greater) from any award or settlement of the Claim

While the Board is confident in the strength of the Claim and therefore the attractiveness of IMM as a vehicle, shareholders should be aware that there is no guarantee that the Option Agreement will be exercised and therefore that the Acquisition Agreement will be entered into on the terms agreed. Accordingly, there is no guarantee that any amounts will be recovered by Pathfinder pursuant to this transaction. Entering into the Acquisition Agreement will be conditional upon shareholder approval pursuant to AIM Rule 15, which, in turn, may lead to the Company being classified as an AIM Rule 15 cash shell.

 

Peter Taylor, Chief Executive Officer of Pathfinder, commented:

 

"This transaction, if completed, will ensure that the full force of a timely and well-funded Claim is brought against the Government of Mozambique and that Pathfinder could participate very considerably in any financial upside which has been independently evaluated to be worth in a range of US$110 million to US$1.5 billion.

 

A great deal of work has gone into preparing to bring a Claim and this now paves the way for AAG to apply its financial firepower to launch it and see it through to conclusion. The biggest hurdle has never been the strength of the Claim - which is assessed by Counsel to be in Pathfinder's favour - but having the funding to bring it. A successful transaction with AAG would remove that hurdle.

 

In the meantime, the £2 million proceeds from the disposal of IMM, if completed, would enable Pathfinder to pursue from a robust financial position other opportunities for value creation within the minerals sector, a number of which are under review."

 

James R Stothard, Chairman of AAG, commented:

 

"I am proud to announce our Option Agreement with Pathfinder to acquire 100 percent of the share capital of IMM in order to vigorously pursue the Claim against the Government of Mozambique. AAG has a proven track record of international claim enforcement. Working with our international legal team at DLA Piper, which also has considerable experience in these types of disputes, we are confident of a successful outcome which will benefit Pathfinder and its shareholders."

 

Background to the Claim

 

In 2011, Pathfinder, via its wholly owned UK subsidiary IMM, was subjected to the unlawful transfer by the Government of Mozambique of the Licence to an unconnected company controlled by the Pathfinder's former local partners without the Company's knowledge or consent. The Licence was until then held by the Company's 99.99%-owned subsidiary Companhia Mineira de Naburi ("CMdN"). The Licence was later sold by the former local partners to a Chinese state-owned company, TZM Resources S.A.

 

Pathfinder has since pursued a multichannel strategy to attempt to recover the Licence, including a successful action through the English High Court to confirm the validity of IMM's ownership of CMdN and through attempts to negotiate settlements with the new Licence holders.

 

In 2020, the Mozambique Supreme Court rejected the Company's application to recognise the English High Court judgment. Having exhausted all other avenues, Pathfinder has since been preparing to bring a claim against the Government of Mozambique, under the Mozambique-United Kingdom Bilateral Investment Treaty (2004) (the "Treaty"), for facilitating the expropriation of the Licence.

In December 2020, Pathfinder received a legal opinion that, subject to the interpretation of the facts and applicable laws as they were known to the Board and Counsel, there is a 55-60 percent prospect of establishing liability on the part of the Government of Mozambique in a Claim under the Treaty.

As part of the Company's preparatory procedures, Pathfinder commissioned Versant Partners LLC ("Versant") to undertake an analysis of the valuation of Pathfinder's potential Claim. The Versant analysis assessed a range of successful scenarios with valuation ranges from a minimum of US$110m for an ex-ante damages award through to US$1.5Bn for an ex-post damages award.

Enquiries:

Pathfinder Minerals Plc

Peter Taylor, Chief Executive Officer

Tel. +44 +44 (0)20 3143 6748

 

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

James Spinney / Ritchie Balmer / Abigail Wellington

Tel. +44 (0)20 7409 3494

 

Vigo Consulting (Public Relations)

Ben Simons / Kate Kilgallen

Tel. +44 (0)20 7390 0234

Email pathfinderminerals@vigoconsulting.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSEDESAEESEIU
Date   Source Headline
30th Oct 20207:00 amRNSHalf-year Report
29th Oct 20207:00 amRNSChange of Admission Date
22nd Oct 20207:05 amRNSTotal Voting Rights
22nd Oct 20207:00 amRNSHolding(s) in Company
19th Oct 202012:08 pmRNSWarrant Exercise, CLN Repayment and TVR
14th Oct 202011:28 amRNSIssue of Equity
7th Oct 202011:57 amRNSWarrant Exercise, CLN Repayment and TVR
11th Sep 202010:49 amRNSHolding(s) in Company
4th Sep 20202:39 pmRNSHolding(s) in Company
4th Sep 20202:36 pmRNSHolding(s) in Company
3rd Sep 20202:40 pmRNSWarrant Exercise, CLN Repayment and TVR
28th Aug 20201:23 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSDirector/PDMR Shareholding
4th Aug 202012:29 pmRNSResult of AGM
13th Jul 20207:00 amRNSNotice of AGM
3rd Jul 20207:00 amRNSDirectorate Change
30th Jun 20207:00 amRNSFinal Results
29th May 202011:05 amRNSSecond Price Monitoring Extn
29th May 202011:00 amRNSPrice Monitoring Extension
29th May 20207:00 amRNSFurther Update re Issue of Equity
28th May 20203:16 pmRNSUpdate Re Issue of Equity
27th May 20207:00 amRNSUpdate on Mozambique Court Proceedings
11th May 20202:45 pmRNSResult of GM / Issue of Equity
24th Apr 20207:00 amRNSNotice of General Meeting
17th Apr 20207:00 amRNSHolding(s) in Company
6th Apr 20207:00 amRNSAlign Research Updates Coverage on Pathfinder
3rd Apr 202011:37 amRNSFundraising
1st Apr 20207:00 amRNSCorporate Update
3rd Jan 202011:20 amRNSCorporate Update
24th Oct 201910:16 amRNSCorporate Update
27th Sep 20191:06 pmRNSHalf-year results
2nd Aug 20197:00 amRNSDirectorate Change
23rd Jul 20193:36 pmRNSResult of AGM
23rd Jul 20197:00 amRNSDirectorate Change
16th Jul 201912:08 pmRNSExercise of Warrants
9th Jul 20197:00 amRNSExercise of Warrants
4th Jul 20199:56 amRNSGrant of Share Options - Replacement
4th Jul 20197:00 amRNSGrant of Share Options
3rd Jul 201912:00 pmRNSExercise of Warrants & Issue of Fee Shares
28th Jun 201911:47 amRNSFinal Results
26th Jun 20197:00 amRNSHolding(s) in Company
25th Jun 20197:36 amRNSHolding(s) in Company
12th Jun 20193:24 pmRNSExercise of Warrants
7th Jun 20191:59 pmRNSExercise of Warrants & Total Voting Rights
6th Jun 20197:00 amRNSExercise of Warrants & Total Voting Rights
5th Jun 20193:02 pmRNSIssue of Equity & Total Voting Rights
3rd Jun 20197:01 amRNSCorporate Update & Directorate Change
3rd Jun 20197:00 amRNSExercise of Warrants
1st May 20191:06 pmRNSHolding(s) in Company
30th Apr 20191:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.